G Parra Selected Research

mycophenolate mofetil (Cellcept)

01/2007	[Effects of mycophenolate mofetil in ischemic acute renal failure in rats]
02/2002	Mycophenolate mofetil aggravates postischemic acute renal failure in rats.
07/2001	Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition.
06/2001	Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.
09/2000	Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit.

3	Acute Kidney Failure (Acute Renal Failure) 01/2007 - 11/2000
2	Hypertension (High Blood Pressure) 07/2001 - 06/2001
1	Ischemia 01/2007
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 07/2003
1	Atherosclerosis (Atheroma) 09/2000
1	Tissue Adhesions 08/2000
1	Serum Sickness 08/2000

5	mycophenolate mofetil (Cellcept)FDA LinkGeneric 01/2007 - 09/2000
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2003
1	AntigensIBA 07/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2001
1	Angiotensin IIIBA 06/2001
1	Mercuric Chloride (Sublimate)IBA 11/2000
1	MelatoninIBA 11/2000
1	CholesterolIBA 09/2000
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2000